The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design.

@article{Lambrakis2019TheAO,
  title={The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design.},
  author={Kristina Lambrakis and John French and Ian A Scott and Thomas G Briffa and David Brieger and Michael E. Farkouh and Harvey D. White and Anthony Ming-Yu Chuang and Kathryn Tiver and S. J. Quinn and Billingsley Kaambwa and Matthew Horsfall and Erin Morton and Derek P B Chew},
  journal={American heart journal},
  year={2019},
  volume={208},
  pages={
          11-20
        }
}
BACKGROUND Elevated troponin level findings among patients presenting with suspected acute coronary syndrome (ACS) or another intercurrent illness undeniably identifies patients at increased risk of mortality. Whilst enhancing our capacity to discriminate risk, the use of high-sensitivity troponin assays frequently identifies patients with myocardial injury (i.e. troponin rise without acute signs of myocardial ischemia) or type 2 myocardial infarction (T2MI; oxygen supply-demand imbalance… CONTINUE READING
2
Twitter Mentions

Citations

Publications citing this paper.

Type 2 Myocardial Infarction: JACC Review Topic of the Week.

  • Journal of the American College of Cardiology
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 23 REFERENCES